CONFERENCE PROCEEDING
Attributable mortality to secondhand smoke exposire in Spain.
More details
Hide details
1
Área de Medicina Preventiva y Salud Pública, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
2
Control del Cáncer, Institut Català d’Oncologia (ICO), L’Hospitalet de Llobregat Barcelona, Spain
3
Hospital Universitario La Paz, Madrid, España. Unidad de Control del Tabaco, Programa de Prevención, Spain
Publication date: 2023-04-25
Corresponding author
Mónica Pérez-Ríos
Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain
Tob. Prev. Cessation 2023;9(Supplement):A112
KEYWORDS
ABSTRACT
Introduction:
Exposure to secondhand smoke (SHS) is associated with an increase in mortality and
morbidity. The aim of this work is to estimate the impact of the exposure to SHS on
mortality in Spain in the population aged 35 and over in the year 2020.
Material and Methods:
Attributable mortality (AM) to SHS was estimated using a prevalence-dependent
method. Prevalence of exposure was derived from a national representative crosssectional
study and relative risks from metanalyses. AM estimations were accompanied
by 95% confidence intervals (95%CI), which were calculated using a naive bootstrap
procedure. AM, globally and by tobacco consumption, was estimated by sex, age group
and cause of death. A sensitivity analysis was performed.
Results:
In Spain, in 2020, 747 (95% CI 676-825) deaths in the population aged 35 and over
were attributed to exposure to SHS, 279 (95%CI 256-306) due to lung cancer and 468
(95% CI 417-523) due to ischemic heart disease. 75.1% of the AM occurred in men,
561 deaths (95% CI 494-634). 60.9% of deaths attributed to SHS exposure occurred in
non-smokers. Including Chronic Obstructive Pulmonary Disease and stroke in the
estimation rose the mortality burden to 2,242 deaths.
Conclusions:
Exposure to SHS is an important cause of death in Spain, associated with 1.5% of all
deaths from lung cancer and ischemic heart disease in the population aged 35 and over.
Most of the AM to SHS occurs in non-smokers. These data reinforce the need for health
authorities to commit to reducing the exposure to SHS in any type of context and
location.
CONFLICTS OF INTEREST
The authors have no conflicts of interest to declare.